medigraphic.com
ISSN 0035-0052 (Impreso)

1998, Número 4

<< Anterior

Rev Mex Pediatr 1998; 65 (4)


Empleo de fármacos por inhalación

Maza TAA

Idioma: Español
Referencias bibliográficas: 40
Paginas: 182-186
Archivo PDF: 118.37 Kb.


RESUMEN

La aerosolterapia es un recurso terapéutico que brinda una ayuda sustancial a los pacientes con patología respiratoria. Se presentan los mecanismos de acción, indicaciones y dosis de los medicamentos utilizados por esta vía, como son: broncodilatadores, mucolíticos, vasoconstrictores y antibióticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ziment I. Fisiopatología y farmacología del esputo. En: Zoment I. Farmacología y terapéutica del aparato respiratorio. Buenos Aires: Ed. Panamericana, 1983; 54-73.

  2. Peter SJ, Peter B. Pharmacology for respiratory care. En: Egan’s Fundamentals of respiratory care. Ed. Mosby. 1990; 450-476.

  3. Shapiro. Farmacología respiratoria. En: Aplicaciones clínicas de la terapéutica respiratoria. Ed. La Prensa Médica Mexicana, 1983.

  4. Rooklin A. Theophylline: is it obsolete for asthma?. J Pediatr 1989; 115: 841-45.

  5. Apple D. Effect of aminophylline when added to metaproterenol sulfate and beclometazone dipropionate aerosol. J Allergy Clin Inmunol 1994; 73: 291-96.

  6. Horton GE. The value and safety of nebulized aminophylline in acute bronchial asthma. J Teen Med Ass 1996; 59: 239-44.

  7. Fontana. Effect of aminophylline aerosol on the bronchial response to ultrasonic mist of distilled water in asthmatic patient. Respiration 1988; 54: 241-46.

  8. Kolbeck RC. Apparent irrelevance of cyclic nucleotide to the relaxation of tracheal smooth muscle induced by theophylline. Lung 1979; 156: 173-83.

  9. Cushiry MJ. Adenosine-induced bronchoconstriction in asthma. Am Rev Resp Dis 1984; 129: 380-84.

  10. Cushley ST, Holgate. Bronchodilator actions of xantines derivates administered by inhalation in asthma. Thorax 1985; 40: 176-79.

  11. Bianco E. Protective effect of inhaled furosemide on allergen induced early and late asthmatic reactions. N Eng J Med 1989; 321: 1069-73.

  12. Geoffey M. Nichol. Effect of inhaled furosemide on metabisulphite and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis 1990; 142: 575-80.

  13. Serdenberg J. Dehing. Inhaled forusemide against cold-air-induced bronchoconstriction in asthmatic children. Arch Dis Child 1992; 67: 214-17.

  14. Pavored I. Inhaled forusemide and excercise-induced asthma: evidence of a role or inhibitory prostanoide. Thorax 1992: 47: 797-800.

  15. Novembre E, Frogia G, Lombardi E, Rest M, Zammarchi E, Verucci A. The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children. J Allergy Clin Immunol 1995; 68: 191-99.

  16. Rastogi A, Luayon M, Ahayl O, Pildes R. Nebulized furosemide in infants with bronchopulmonary dysplasia. J Pediatr 1995; 125: 976-79.

  17. Kugelman A, Durand M, Garg M. Pulmonary efect of inhaled furosemide in ventiled infants with severe bronchopulmonary dysplasia. Pediatrics 1997; 99: 71-76.

  18. Najak Z, Harris J, Lazzara A, Pruitt A. Pulmonary effect of inhaled furosemide in preterm infants with lung disease. J Pediatr 1983; 102: 758-63.

  19. Coupe G, Brownnes PJ. Nebulized adrenaline in acute severe asthma. Comparision with salbutamol. Eur F Respir D 1987; 71: 227-32.

  20. Nutman J, Deakins K, Baldesare K. Prospective, randomized, double-blind study comparing racemic epinephrine and L-epinephrine in treatmen of post intubation laryngeal edema. Pediatr Resp 1986; 20: 182.

  21. Remington S, Meakin G. Nebulized adrenaline 1:1000 in the treatment of croup. Anaesthesia 1986; 41: 923-26.

  22. Yaheskel W, Klein BL, Douglas A, Boening , Young G, Chamberlain J, O’Donell R. Estudio doble ciego con distribución al azar, comparando aerosoles de L adrenalina y adrenalina racémica en el tratamiento de la laringotraqueítis. Pediatrics 1992; 89: 302-6.

  23. Choudry AK. Nebulized adrenaline. Anaesthesia 1987; 42: 321.

  24. Mc Donogh AJ. The use of steroids and nebulized adrenaline in the treatmen of viral croup over a seven year period in a District Hospital. Anaesth Intens Care 1994; 22: 175-78.

  25. Kritjensen KC, Lodrup C, Wennergren G, Stranegard J, Carlsen KH. Nebulized adrenaline in the treatmen of acute bronchiolitis in infant and toddlers. Arch Dis Child 1993; 69: 650-54.

  26. Sanchez I, De Koster J, Powell R. Wolstein R, Chemick V. Effect of racemic epinephrine and salbutamol or clinical score on pulmonary mechanics in infant with bronchiolitis. J Pediatr 1993; 12: 145-51.

  27. Solano C. Farmacología de la terapia respiratoria. En: Fundamentos y aplicaciones de la terapia respiratoria. Ed. Celsus 1990; 137-39.

  28. Lester MA. Mucolytic therapies. In: Pulmonary and critical care pharmacology and therapeutics. International Ed. Mc Graw-Hill 1996; 681-94.

  29. App E, King M, Helfsrieder R, Kohler D, Matthys H. Acute and long term amiloride inhalation in cystic fibrosis lung disease. Am Rev Respir Dis 1990; 141: 605-12.

  30. Thomas SHL, O’Doherty MJ, Graham A, Page C, Blower P, Geddes DM, Nunan T. Pulmonary deposition of nebulized amiloride in cystic fibrosis. Comparison of two nebulizers. Thorax 1991; 43: 717-21.

  31. Knwoles M, Church N, Walener W, Yankeskas J, Gilligan P, King M, Loyd P. A pilot study of aerolized for the treatment of lung disease in cystic fibrosis. N Eng J Med 1990; 322: 1189-94.

  32. Puchelle. Physical and functional properties of airway secretions in cystic fibrosis. Therapeutic approaches. Respiration 1995; 62: 2-12.

  33. Littlewood JM, Smye SW, Cunliffe H. Aerosol antibiotic treatment in cystic fibrosis. Arch Dis Child 1993; 68: 788-92.

  34. Smith AL, Ramsey B. Aerosol administration of antibiotics. Respiration 1995; 62: 19-24.

  35. Prigal SJ, Tchertkoff V, Brooks A. Streptomycin blood level following inhalation of steam generated aerosol. Dis Chest 1950; 17: 304-11.

  36. Shaad VB, Wedwood-Krucko J, Sutter S, Kramer R. Efficacy of inhaled amikacin as adjunt to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. Pediatr Pulmonol 1989; 7: 265-71.

  37. Smith AI, Ramsery B, Hedges D. Saffety of aerosol tobramycin administration for 3 months to patient with cystic fibrosis. Pediat Pulmonol 1989; 7: 272-75.

  38. MacLusky I, Gold R, Corey H, Levinson H. Long term effects of inhaled tobramycin in patient with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1997; 6: 91-98.

  39. Steinkamp G, Tummier B, Gappa M. Long-tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989; 6: 91-98.

  40. Ramsey BW, Horkin HI, Ersenberg JD. Efficacy of aerolized tobramycin in patient with cystic fibrosis. N Eng J Med 1993; 328: 1740-46.




2020     |     www.medigraphic.com